Global leader in specialty therapy selects Kneat for Digitization Validation by Investing.com
LIMERICK, Ireland, January 9, 2025 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (OTCQX: KSIOF)a leader in the digitization and automation of validation and quality processes, is pleased to announce that a leading global therapeutics company (the Company) has signed a three-year master services agreement with Kneat to digitize the validation process.
Headquartered in Europe, the company employs more than 20,000 people and operates in more than 100 countries, with more than ten manufacturing locations globally. The company provides supplies to companies operating across the life sciences, including research, clinical trials, manufacturing, diagnostics and treatment. It also develops, manufactures and delivers innovative healthcare services and solutions to diagnose and treat a range of diseases, including rare conditions, to millions of patients worldwide.
With capabilities across the value chain from research and development to manufacturing and final distribution, the company maintains a number of systems and processes that require validation. They will initially use Kneat Gx for commissioning, qualification and validation of production equipment and facilities.
This win continues our strong momentum attracting global life science leaders to our platform, said Eddie Ryan, Chief Executive Officer of Kneat. We look forward to supporting this company on their digitization journey for all their validation processes.
About Kneat
Kneat Solutions provides leading companies in highly regulated industries with unmatched efficiency in validation and compliance through its Kneat Gx digital validation platform. As an industry leader in customer satisfaction, Kneat boasts an excellent implementation track record, thanks to our user-friendly design, expert support and on-demand training academy. Kneat Gx is a leading digital validation platform that enables highly regulated companies to manage any validation discipline end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated and compliant with 21 CFR Part 11/Annex 11. Multiple independent customer studies report up to 40% reduction in manual effort and documentation validation cycle time, with a higher standard of compliance.
Cautionary Statements and Forward-Looking Statements
Except for statements of historical fact contained herein, certain information presented constitutes forward-looking information within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the use and implementation of Kneat’s software within the client validation process, the customer’s ability and intent to scale the use of Kneat’s software within the customer’s organization and compliance of Kneat’s platform with regulatory audit and inspection. Although such forward-looking statements are made by Kneat, as set forth in this press release, in good faith and which Kneat believes have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events anticipated in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, as they involve risks and uncertainties.
Kneat undertakes no obligation to publicly announce any changes to any forward-looking statement, except as required by applicable securities laws. Investors should not assume that the failure to update a previously issued forward-looking statement constitutes a reaffirmation of that statement. Any further reliance on forward-looking statements is at the investor’s own risk.
For further information:
Katie Keita, Kneat Investor Relations
Q: + 1 902-450-2660
Email: investors@kneat.com
Source: kneat.com, inc.
